New stock news | Yifang Biotechnology (688382.SH) Hong Kong IPO prospectus invalidated

According to Choicetour Financial APP, the prospectus of Yifang Biotechnology (Shanghai) Co., Ltd. (referred to as Yifang Biotechnology, 688382.SH) submitted for listing on the Hong Kong Stock Exchange on January 1, 2026 expires after 6 months, on July 1, 2026, with CITIC Securities as its exclusive sponsor.